Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with T2 to T4, N0 and N1 breast cancer

Ítems similars

• Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer
  per: Allevi, G, et al.
  Publicat: (2013)
• Increased pathological complete response rate after a long-term neoadjuvant letrozole treatment in postmenopausal oestrogen and/or progesterone receptor-positive breast cancer.
  per: Allevi, G, et al.
  Publicat: (2013)
• Molecular oncology and the neoadjuvant setting: the perfect blend for treatment personalization and clinical trial design.
  per: Generali, D, et al.
  Publicat: (2011)
• The prolyl hydroxylase enzymes are positively associated with hypoxia-inducible factor-1α and vascular endothelial growth factor in human breast cancer and alter in response to primary systemic treatment with epirubicin and tamoxifen
  per: Fox, S, et al.
  Publicat: (2011)
• Anti-angiogenic effect of tamoxifen combined with epirubicin in breast cancer patients.
  per: Mele, T, et al.
  Publicat: (2010)